Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Primary Hypertension
NCT04406129Phase 1Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Mar 2021
- Primary completion
- Feb 2022
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in primary hypertension comparing FMT capsules with Placebo capsules (2 arms). Primary endpoint: Change for Office Systolic Blood Pressure at Day 30. Status: unknown.
02
Drugs
fecal microbiome transplant
03
Conditions
primary hypertension
Beyond the preview
Go deeper on NCT04406129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04406129.